Survey: Understanding views of neurology trainees in the UK about MS as an area of sub-specialty interest

16 April, 2020 | Posted in:

Do you want to develop specialist skills in multiple sclerosis? Research undertaken by Dr Riffat Tanveer has shown trainee neurologists largely feel unsupported in developing skills in this specialist area. Complete our short survey to help us understand your views as a neurology trainee about pursuing a neurology sub-speciality. Start Survey Dear Colleague, I am […]

Continue Reading »

Live webinars: COVID-19 and multiple sclerosis

17 March, 2020 | Posted in:

As the coronavirus (COVID-19) spreads, there is a clear need to advise patients with MS on what to do in relation to their treatment. The MS Academy is hosting a series of webinars on what advice to give our patients with MS. These meetings will be held as live video conferences for an interactive discussion […]

Continue Reading »

New MS prevalence data and smoking statistics

17 March, 2020 | Posted in:

A new briefing from Public Health England has issued new prevalence data on MS and links with smoking. Seeking insight into the characteristics of people with MS, the briefing was developed in collaboration with the MS Society and using the THIN dataset.   The evidence, which was gathered over an eight year period from financial […]

Continue Reading »

Latest data shows upward trajectory for avoidable MS emergency admissions continues

3 February, 2020 | Posted in:

The latest Hospital Episode Statistics (HES) data shows that emergency hospital admissions for people with multiple sclerosis (MS) continue to rise despite many of them being avoidable through preventative care.  MS Academy have partnered with healthcare intelligence provider Wilmington Healthcare to analyse the latest HES data and compare it to the previous two years, and […]

Continue Reading »

New year, new MasterClasses!

3 January, 2020 | Posted in: , ,

This year we are excited to announce two new MasterClasses to our range of educational offerings: the Leadership MasterClass and the Alzheimer’s MasterClass.  Leadership MasterClass Our Leadership MasterClass will commence with its first nine delegates this February and promises to be an exciting and innovative course, drawing on interactive workshops, coaching techniques and a practical […]

Continue Reading »

First ever NICE guidance on cannabis-based medicinal products

18 November, 2019 | Posted in: ,

NICE has published its first ever guidance on cannabis-based medicinal products. NG144 has just been published this November and outlines guidance across 4 key areas (fig 1): chemotherapy-induced nausea and vomiting, chronic pain, spasticity, and treatment-resistant epilepsy.  The National Council of Health and Care Excellence (NICE) have examined the evidence for the use of both […]

Continue Reading »

Neuropharmacy intermodule project winner announced

15 October, 2019 | Posted in: ,

Our first Neuropharmacy MasterClass intermodule projects were presented and voted as the group met for their second module. Having looked extensively at multiple sclerosis (MS) and headache in module one, the delegates met for another two-day residential focussing on epilepsy and Parkinson’s. During the course, delegates were invited to present posters outlining the key findings […]

Continue Reading »

Neuropharmacist faculty member’s project featured in MS Trust publication

11 July, 2019 | Posted in: ,

The MS Trust has just released its fifth issue of ‘MS in Practice’, a valuable resource outlining examples of positive practice and reviewing the practical application of new guidance for those with an interest in multiple sclerosis (MS). This particular issue features an article about the disease-modifying therapy (DMT) cost calculator, developed by neuropharmacist and […]

Continue Reading »